SEC Form 4 research
| Issuer | ONCOGENEX PHARMACEUTICALS, INC. |
|---|---|
| Tickers | OGXI, ACHV, OXGI, SNUS |
| Reporting owners | 67 |
| Officers and directors | 15 |
| Last public filing | 2026-10-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-05 | Halladay Benjamin | A | 200,000 | $0 | Not reported |
| 2026-10-06 | 2026-10-05 | Halladay Benjamin | A | 200,000 | $0 | Not reported |
| 2026-08-21 | 2026-08-19 | Stewart Richard Alistair | S | 20,626 | $8.49 | Not reported |
| 2026-07-29 | 2026-07-27 | Sellig Thomas | A | 16,700 | $0 | Not reported |
| 2026-07-29 | 2026-07-27 | Sellig Thomas | A | 25,000 | $0 | Not reported |
| 2026-07-29 | 2026-07-27 | Martin Christopher Nathan | A | 16,700 | $0 | Not reported |
| 2026-07-29 | 2026-07-27 | Martin Christopher Nathan | A | 25,000 | $0 | Not reported |
| 2026-07-29 | 2026-07-27 | Royston Aaron | A | 16,700 | $0 | Not reported |
| 2026-07-29 | 2026-07-27 | Royston Aaron | A | 25,000 | $0 | Not reported |
| 2026-07-29 | 2026-07-27 | Waldman Reid Alexander | A | 16,700 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.